Variant report
Variant | esv3420599 |
---|---|
Chromosome Location | chr9:13957602-13959100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537526334 | chr9:13957676-13957677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557556342 | chr9:13957688-13957689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188588916 | chr9:13957689-13957690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140661788 | chr9:13957699-13957700 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553260161 | chr9:13957702-13957703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76492423 | chr9:13957712-13957713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538694841 | chr9:13957730-13957731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs55964819 | chr9:13957768-13957769 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs575727862 | chr9:13957769-13957770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530065688 | chr9:13957777-13957778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544357189 | chr9:13957782-13957783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs56021345 | chr9:13957797-13957798 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs574563914 | chr9:13957821-13957822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540390340 | chr9:13957822-13957823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12343984 | chr9:13957914-13957915 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs532436544 | chr9:13957976-13957977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552234172 | chr9:13957977-13957978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562320804 | chr9:13957991-13957992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531305258 | chr9:13957996-13957997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547996202 | chr9:13957999-13958000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568106749 | chr9:13958006-13958007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536450259 | chr9:13958016-13958017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546786246 | chr9:13958024-13958025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566866440 | chr9:13958051-13958052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12344920 | chr9:13958052-13958053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200269180 | chr9:13958060-13958061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551912686 | chr9:13958069-13958070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563374773 | chr9:13958071-13958072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575571941 | chr9:13958085-13958086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538206861 | chr9:13958103-13958104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554777803 | chr9:13958123-13958124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574039434 | chr9:13958126-13958127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111797335 | chr9:13958151-13958152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369911649 | chr9:13958154-13958155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543151165 | chr9:13958161-13958162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527493073 | chr9:13958197-13958198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574831970 | chr9:13958217-13958218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145510555 | chr9:13958244-13958245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560372181 | chr9:13958251-13958252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373319322 | chr9:13958261-13958262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117495602 | chr9:13958273-13958274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568700318 | chr9:13958316-13958317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562767448 | chr9:13958317-13958318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531217999 | chr9:13958397-13958398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35419471 | chr9:13958438-13958439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397801879 | chr9:13958439-13958440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548121364 | chr9:13958448-13958449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374500035 | chr9:13958474-13958475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527377892 | chr9:13958583-13958584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113348214 | chr9:13958593-13958594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:13933600-13961600 | Weak transcription | Psoas Muscle | Psoas |
2 | chr9:13940400-13962000 | Weak transcription | Left Ventricle | heart |
3 | chr9:13956400-13957800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr9:13956600-13957800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr9:13956600-13962200 | Weak transcription | Colon Smooth Muscle | Colon |
6 | chr9:13956800-13957800 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr9:13957400-13957800 | Weak transcription | Aorta | Aorta |
8 | chr9:13957400-13958600 | Weak transcription | Fetal Lung | lung |
9 | chr9:13957400-13958800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr9:13957400-13960000 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr9:13957400-13960000 | Weak transcription | Fetal Heart | heart |
12 | chr9:13957600-13957800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr9:13957600-13958800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr9:13957800-13958000 | Enhancers | Aorta | Aorta |
15 | chr9:13957800-13958800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
16 | chr9:13957800-13961400 | Weak transcription | Fetal Muscle Leg | muscle |
17 | chr9:13958600-13960400 | Enhancers | Fetal Lung | lung |
18 | chr9:13958800-13959600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr9:13958800-13963600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr9:13959000-13959200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |